NIH clinical trial tests a new vaccine for COVID-19 in humans. While still in early stages, the team hopes to make it available as soon as possible.
Low- and middle-income countries overlooked in COVID-19 response to date
Older individuals in low- and middle-income countries are considered to be the most vulnerable to COVID-19 but have yet to be properly acknowledged in global planning for the disease.
A more sensitive test for COVID-19
Doctors in Wuhan show that a chest CT is a more sensitive test for COVID 19 than the current standard.
Blocking key protein halts spread of cervical cancer tumors
New findings shed light on how cervical cancer spreads to the lymph nodes, opening the door for treatments that could stop the process.
Shira Joudan, tackling PFAS and environmental contaminants with chemistry
Chemist Shira Joudan discusses environmental contaminants, setting up at a new university, and building a supportive community.
A universal vaccine could eliminate the need to track evolving strains
An RNA-based vaccine approach that is effective against all virus strains and safe for infants and immunocompromised individuals.
Peptides light up in the brain for early diagnosis of Alzheimer’s
Peptide-laden vesicles light up in the presence of amyloid beta, providing an early diagnostic test (and possible treatment) for Alzheimer’s.
How research into existential risk will help safeguard humanity
Florian Jehn combines pragmatism with optimism when considering potential threats to human civilization.
New study reveals surprising impact of screen time on the developing brain
Researchers have found a trade-off with screen time and the cognition, behavior, and brains volume of adolescent and young children.
Antimicrobial resistance is an unwinnable arms race
Experts argue a new approach is needed so that we are less reliant on antimicrobial drugs, where less use means less resistance.